Mind Medicine MindMed (MNMD)
(Delayed Data from NSDQ)
$7.68 USD
+0.37 (5.06%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $7.67 -0.01 (-0.13%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth A Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MNMD 7.68 +0.37(5.06%)
Will MNMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MNMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MNMD
Is Mind Medicine MindMed (MNMD) Outperforming Other Medical Stocks This Year?
Are Medical Stocks Lagging Mind Medicine MindMed (MNMD) This Year?
MNMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why
MindMed's (MNMD) Anxiety Drug Gets FDA Breakthrough Therapy Tag
What Makes Mind Medicine (MindMed) Inc. (MNMD) a New Buy Stock
Other News for MNMD
MindMed And Other Psychedelic Stocks Brace For FDA's Decision On MDMA Therapy
MindMed to Present at Canaccord Genuity?s 44th Annual Growth Conference
MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update
Commit To Buy Mind Medicine Mindmed At $6, Earn 26.7% Annualized Using Options
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves